101 related articles for article (PubMed ID: 30730058)
21. Characterization of focal hepatic tumors. Value of two-phase scanning with spiral computed tomography.
Choi BI; Han JK; Cho JM; Choi DS; Han MC; Lee HS; Kim CY
Cancer; 1995 Dec; 76(12):2434-42. PubMed ID: 8625068
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular Carcinoma: Retrospective Evaluation of the Correlation Between Gadobenate Dimeglumine-Enhanced Magnetic Resonance Imaging and Pathologic Grade.
Huang X; Xiao Z; Zhang Y; Lin N; Xiong M; Huang X; Chen Q; Cao D
J Comput Assist Tomogr; 2018; 42(3):365-372. PubMed ID: 29369947
[TBL] [Abstract][Full Text] [Related]
23. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
Hohmann J; Skrok J; Puls R; Albrecht T
Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
[TBL] [Abstract][Full Text] [Related]
24. Superb microvascular imaging technology for ultrasound examinations: Initial experiences for hepatic tumors.
Lee DH; Lee JY; Han JK
Eur J Radiol; 2016 Nov; 85(11):2090-2095. PubMed ID: 27776663
[TBL] [Abstract][Full Text] [Related]
25. Detection of small hepatocellular carcinoma: can gadoxetic acid-enhanced magnetic resonance imaging replace combining gadopentetate dimeglumine-enhanced and superparamagnetic iron oxide-enhanced magnetic resonance imaging?
Kim YK; Kim CS; Han YM; Park G
Invest Radiol; 2010 Nov; 45(11):740-6. PubMed ID: 20644488
[TBL] [Abstract][Full Text] [Related]
26. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings.
Ishigami K; Yoshimitsu K; Nishihara Y; Irie H; Asayama Y; Tajima T; Nishie A; Hirakawa M; Ushijima Y; Okamoto D; Taketomi A; Honda H
Radiology; 2009 Feb; 250(2):435-43. PubMed ID: 19095782
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles.
Grangier C; Tourniaire J; Mentha G; Schiau R; Howarth N; Chachuat A; Grossholz M; Terrier F
J Comput Assist Tomogr; 1994; 18(6):888-96. PubMed ID: 7962795
[TBL] [Abstract][Full Text] [Related]
28. Contrast-enhanced sonography in the characterization of small hepatocellular carcinomas in cirrhotic patients: comparison with contrast-enhanced ultrafast magnetic resonance imaging.
Giorgio A; De Stefano G; Coppola C; Ferraioli G; Esposito V; Di Sarno A; Giorgio V; De Stefano M; Sangiovanni V; Liorre G; Del Viscovo L
Anticancer Res; 2007; 27(6C):4263-9. PubMed ID: 18214030
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients.
Li K; Su Z; Xu E; Huang Q; Zeng Q; Zheng R
BMC Cancer; 2017 Jan; 17(1):61. PubMed ID: 28103837
[TBL] [Abstract][Full Text] [Related]
30. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
[TBL] [Abstract][Full Text] [Related]
31. Ferumoxide-enhanced MR imaging of hepatocellular carcinoma: correlation with histologic tumor grade and tumor vascularity.
Kato H; Kanematsu M; Kondo H; Goshima S; Matsuo M; Hoshi H; Moriyama N
J Magn Reson Imaging; 2004 Jan; 19(1):76-81. PubMed ID: 14696223
[TBL] [Abstract][Full Text] [Related]
32. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
[TBL] [Abstract][Full Text] [Related]
33. Differential diagnosis of early homogeneously enhancing hepatocellular carcinoma and hemangioma by two-phase CT.
Hanafusa K; Ohashi I; Gomi N; Himeno Y; Wakita T; Shibuya H
J Comput Assist Tomogr; 1997; 21(3):361-8. PubMed ID: 9135641
[TBL] [Abstract][Full Text] [Related]
34. Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging.
Sano K; Ichikawa T; Motosugi U; Sou H; Muhi AM; Matsuda M; Nakano M; Sakamoto M; Nakazawa T; Asakawa M; Fujii H; Kitamura T; Enomoto N; Araki T
Radiology; 2011 Dec; 261(3):834-44. PubMed ID: 21998047
[TBL] [Abstract][Full Text] [Related]
35. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of hemodynamic imaging findings of hypervascular hepatocellular carcinoma: comparison between dynamic contrast-enhanced magnetic resonance imaging using radial volumetric imaging breath-hold examination with k-space-weighted image contrast reconstruction and dynamic computed tomography during hepatic arteriography.
Kurozumi M; Fujinaga Y; Kitou Y; Yamada A; Ohya A; Adachi Y; Tsukahara Y; Nickel MD; Maruyama K; Uehara T; Miyagawa SI; Kadoya M
Jpn J Radiol; 2018 Apr; 36(4):295-302. PubMed ID: 29327116
[TBL] [Abstract][Full Text] [Related]
37. Assessment of hepatocellular carcinoma using apparent diffusion coefficient and diffusion kurtosis indices: preliminary experience in fresh liver explants.
Rosenkrantz AB; Sigmund EE; Winnick A; Niver BE; Spieler B; Morgan GR; Hajdu CH
Magn Reson Imaging; 2012 Dec; 30(10):1534-40. PubMed ID: 22819175
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
[TBL] [Abstract][Full Text] [Related]
39. Contrast-enhanced computed tomography plus gadolinium-ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging for gross classification of hepatocellular carcinoma.
Chen C; Zhao H; Fu X; Huang L; Tang M; Yan X; Sun S; Jia W; Mao L; Shi J; Chen J; He J; Zhu J; Qiu Y
Oncotarget; 2017 May; 8(18):29741-29750. PubMed ID: 28392502
[TBL] [Abstract][Full Text] [Related]
40. Feasibility and reproducibility of BOLD and TOLD measurements in the liver with oxygen and carbogen gas challenge in healthy volunteers and patients with hepatocellular carcinoma.
Bane O; Besa C; Wagner M; Oesingmann N; Zhu H; Fiel MI; Taouli B
J Magn Reson Imaging; 2016 Apr; 43(4):866-76. PubMed ID: 26417669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]